Intimation regarding closure of trading window
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals has informed the BSE that its trading window will be closed for all Directors, Promoters, Designated Employees, Connected Persons, and their immediate relatives starting Wednesday, October 01, 2025. The closure is in connection with the declaration of the company's Un-audited Financial Results for the half year ending September 30, 2025. The trading window will reopen 48 hours after the financial results are officially declared to the Stock Exchange. The intimation was signed by Managing Director Bharat Sharma (DIN: 00077026) and is filed in compliance with the company's insider trading code of conduct.
This is a routine compliance filing and signals that the company's H2 (April-September 2025) unaudited financial results will be announced in early October. Retail investors should watch for the results declaration, as the trading window for insiders reopens 48 hours after the announcement. No immediate action is required from existing shareholders.